{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"title":"number of different SdAb for subject 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"title":"number of different SdAb for subject 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"20"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"title":"number of different SdAb for subject 5"}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"}],"units":"Participants"}],"description":"Absolute amount of unique sdAbs obtained per patient","groups":[{"description":"Only 1 arm/group in this trial","id":"OG000","title":"Patients With a Clinically Suspected or Pathologically Confirmed Multiple Myeloma."}],"paramType":"NUMBER","populationDescription":"Per participant, the number of different SdAb generated are reported.","reportingStatus":"POSTED","timeFrame":"Within 2 years after study completion","title":"Amount of Paraprotein-targeting sdAbs Generated Per Patient","type":"PRIMARY","unitOfMeasure":"unique sdAbs"}